nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefotetan—ALB—chronic obstructive pulmonary disease	0.871	1	CbGaD
Cefotetan—ALB—Prednisone—chronic obstructive pulmonary disease	0.0439	1	CbGbCtD
Cefotetan—Vaginal moniliasis—Salbutamol—chronic obstructive pulmonary disease	0.00377	0.0463	CcSEcCtD
Cefotetan—Vulvovaginal candidiasis—Salbutamol—chronic obstructive pulmonary disease	0.00362	0.0445	CcSEcCtD
Cefotetan—Vulvovaginal mycotic infection—Salbutamol—chronic obstructive pulmonary disease	0.00348	0.0428	CcSEcCtD
Cefotetan—Phlebitis—Aminophylline—chronic obstructive pulmonary disease	0.00223	0.0274	CcSEcCtD
Cefotetan—Discomfort—Roflumilast—chronic obstructive pulmonary disease	0.00146	0.0179	CcSEcCtD
Cefotetan—Toxic epidermal necrolysis—Montelukast—chronic obstructive pulmonary disease	0.00129	0.0159	CcSEcCtD
Cefotetan—Eosinophilia—Montelukast—chronic obstructive pulmonary disease	0.00122	0.0151	CcSEcCtD
Cefotetan—Gastrointestinal pain—Roflumilast—chronic obstructive pulmonary disease	0.00116	0.0142	CcSEcCtD
Cefotetan—Urticaria—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.0138	CcSEcCtD
Cefotetan—Abdominal pain—Roflumilast—chronic obstructive pulmonary disease	0.00112	0.0138	CcSEcCtD
Cefotetan—Stevens-Johnson syndrome—Montelukast—chronic obstructive pulmonary disease	0.00109	0.0134	CcSEcCtD
Cefotetan—Cefpiramide—ALB—chronic obstructive pulmonary disease	0.00108	0.252	CrCbGaD
Cefotetan—Hypersensitivity—Roflumilast—chronic obstructive pulmonary disease	0.00104	0.0128	CcSEcCtD
Cefotetan—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.001	0.0123	CcSEcCtD
Cefotetan—Diarrhoea—Roflumilast—chronic obstructive pulmonary disease	0.000968	0.0119	CcSEcCtD
Cefotetan—Haemoglobin—Salbutamol—chronic obstructive pulmonary disease	0.000959	0.0118	CcSEcCtD
Cefotetan—Haemorrhage—Salbutamol—chronic obstructive pulmonary disease	0.000955	0.0117	CcSEcCtD
Cefotetan—Anaphylactic shock—Aminophylline—chronic obstructive pulmonary disease	0.000944	0.0116	CcSEcCtD
Cefotetan—Cefonicid—ALB—chronic obstructive pulmonary disease	0.000937	0.219	CrCbGaD
Cefotetan—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000936	0.0115	CcSEcCtD
Cefotetan—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0009	0.0111	CcSEcCtD
Cefotetan—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000892	0.011	CcSEcCtD
Cefotetan—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000891	0.011	CcSEcCtD
Cefotetan—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000841	0.0103	CcSEcCtD
Cefotetan—Cefmetazole—ALB—chronic obstructive pulmonary disease	0.000825	0.193	CrCbGaD
Cefotetan—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000772	0.00949	CcSEcCtD
Cefotetan—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00075	0.00922	CcSEcCtD
Cefotetan—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.000747	0.00919	CcSEcCtD
Cefotetan—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00918	CcSEcCtD
Cefotetan—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000746	0.00918	CcSEcCtD
Cefotetan—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00074	0.0091	CcSEcCtD
Cefotetan—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00074	0.0091	CcSEcCtD
Cefotetan—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000728	0.00895	CcSEcCtD
Cefotetan—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000718	0.00883	CcSEcCtD
Cefotetan—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000718	0.00883	CcSEcCtD
Cefotetan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000707	0.0087	CcSEcCtD
Cefotetan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000704	0.00865	CcSEcCtD
Cefotetan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000704	0.00865	CcSEcCtD
Cefotetan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000699	0.0086	CcSEcCtD
Cefotetan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000695	0.00855	CcSEcCtD
Cefotetan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000689	0.00847	CcSEcCtD
Cefotetan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000678	0.00834	CcSEcCtD
Cefotetan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000668	0.00821	CcSEcCtD
Cefotetan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000656	0.00806	CcSEcCtD
Cefotetan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000646	0.00794	CcSEcCtD
Cefotetan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00063	0.00774	CcSEcCtD
Cefotetan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0006	0.00738	CcSEcCtD
Cefotetan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000595	0.00732	CcSEcCtD
Cefotetan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000594	0.00731	CcSEcCtD
Cefotetan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000587	0.00722	CcSEcCtD
Cefotetan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000587	0.00722	CcSEcCtD
Cefotetan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000575	0.00708	CcSEcCtD
Cefotetan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000571	0.00702	CcSEcCtD
Cefotetan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000571	0.00702	CcSEcCtD
Cefotetan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00698	CcSEcCtD
Cefotetan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000568	0.00698	CcSEcCtD
Cefotetan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00698	CcSEcCtD
Cefotetan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000568	0.00698	CcSEcCtD
Cefotetan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000566	0.00696	CcSEcCtD
Cefotetan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000561	0.0069	CcSEcCtD
Cefotetan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000561	0.0069	CcSEcCtD
Cefotetan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000561	0.00689	CcSEcCtD
Cefotetan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000559	0.00687	CcSEcCtD
Cefotetan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00684	CcSEcCtD
Cefotetan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000556	0.00684	CcSEcCtD
Cefotetan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00682	CcSEcCtD
Cefotetan—Cefoperazone—ALB—chronic obstructive pulmonary disease	0.000553	0.129	CrCbGaD
Cefotetan—Haemoglobin—Prednisolone—chronic obstructive pulmonary disease	0.00055	0.00677	CcSEcCtD
Cefotetan—Haemorrhage—Prednisolone—chronic obstructive pulmonary disease	0.000548	0.00673	CcSEcCtD
Cefotetan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000539	0.00663	CcSEcCtD
Cefotetan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00659	CcSEcCtD
Cefotetan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000536	0.00659	CcSEcCtD
Cefotetan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000529	0.00651	CcSEcCtD
Cefotetan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000529	0.00651	CcSEcCtD
Cefotetan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000529	0.0065	CcSEcCtD
Cefotetan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000518	0.00637	CcSEcCtD
Cefotetan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000508	0.00625	CcSEcCtD
Cefotetan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000508	0.00625	CcSEcCtD
Cefotetan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.0005	0.00615	CcSEcCtD
Cefotetan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000498	0.00612	CcSEcCtD
Cefotetan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000491	0.00604	CcSEcCtD
Cefotetan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000491	0.00604	CcSEcCtD
Cefotetan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000481	0.00592	CcSEcCtD
Cefotetan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.00048	0.0059	CcSEcCtD
Cefotetan—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000465	0.00572	CcSEcCtD
Cefotetan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000464	0.00571	CcSEcCtD
Cefotetan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.00562	CcSEcCtD
Cefotetan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000457	0.00562	CcSEcCtD
Cefotetan—Cefazolin—ALB—chronic obstructive pulmonary disease	0.000454	0.106	CrCbGaD
Cefotetan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000453	0.00557	CcSEcCtD
Cefotetan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000453	0.00557	CcSEcCtD
Cefotetan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000452	0.00556	CcSEcCtD
Cefotetan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000452	0.00556	CcSEcCtD
Cefotetan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000447	0.0055	CcSEcCtD
Cefotetan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000444	0.00546	CcSEcCtD
Cefotetan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000443	0.00545	CcSEcCtD
Cefotetan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000431	0.0053	CcSEcCtD
Cefotetan—Ceftriaxone—ALB—chronic obstructive pulmonary disease	0.00043	0.101	CrCbGaD
Cefotetan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000428	0.00526	CcSEcCtD
Cefotetan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000427	0.00525	CcSEcCtD
Cefotetan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000427	0.00525	CcSEcCtD
Cefotetan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000427	0.00525	CcSEcCtD
Cefotetan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000418	0.00514	CcSEcCtD
Cefotetan—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000413	0.00508	CcSEcCtD
Cefotetan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000403	0.00495	CcSEcCtD
Cefotetan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000401	0.00493	CcSEcCtD
Cefotetan—Haemoglobin—Prednisone—chronic obstructive pulmonary disease	0.0004	0.00492	CcSEcCtD
Cefotetan—Haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000398	0.00489	CcSEcCtD
Cefotetan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000389	0.00478	CcSEcCtD
Cefotetan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000309	0.0038	CcSEcCtD
Cefotetan—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.0003	0.00369	CcSEcCtD
Cefotetan—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000291	0.00358	CcSEcCtD
Cefotetan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000287	0.00352	CcSEcCtD
Cefotetan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000283	0.00348	CcSEcCtD
Cefotetan—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00302	CcSEcCtD
Cefotetan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000245	0.00301	CcSEcCtD
Cefotetan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000231	0.00284	CcSEcCtD
Cefotetan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000231	0.00284	CcSEcCtD
Cefotetan—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000225	0.00276	CcSEcCtD
Cefotetan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00275	CcSEcCtD
Cefotetan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00275	CcSEcCtD
Cefotetan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000208	0.00256	CcSEcCtD
Cefotetan—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00246	CcSEcCtD
Cefotetan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000193	0.00238	CcSEcCtD
Cefotetan—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00018	0.00221	CcSEcCtD
Cefotetan—Rash—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00219	CcSEcCtD
Cefotetan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00219	CcSEcCtD
Cefotetan—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000168	0.00206	CcSEcCtD
